Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study-Reference-Cited by-同舟云学术

Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study

Published:2021-03 Issue:3 Volume:39 Page:195.e1-195.e6
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Nouhaud François-Xavier,Chakroun Marouene,Lenormand Claire,ouzaid Idir,Peyronnet Benoit,Gryn Alexandre,Prudhomme Thomas,Grafeille Vivien,Soulié Michel,Roumiguié Mathieu,Verhoest Grégory,Xylinas Evanguelos,Bouzouita Abderrazak,Chebil Mohamed,Pfister Christian

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference19 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

3. Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy;Sun;Eur J Cancer,2012

4. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy;Schrier;Eur Urol,2004

5. Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy;Pietzak;Eur Urol,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status;Urologic Oncology: Seminars and Original Investigations;2024-10

2. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy;European Urology Oncology;2023-12

3. Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure;World Journal of Urology;2023-02-22

4. Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model;Frontiers in Genetics;2022-09-15

5. Optimisation de la prise en charge des tumeurs de vessie non infiltrant le muscle : du diagnostic au traitement;Progrès en Urologie - FMC;2022-06